Joint FP7 BAMMBO-GiaVap-SunBioPath Meeting, Mercure Hotel Brussels, Belgium, Jan 21st-23rd, 2013.
Joint FP7 BAMMBO-GiaVap-SunBioPath Meeting, Mercure Hotel Brussels, Belgium, Jan 21st-23rd, 2013. Pl…
Effective & Entrepreneurial Communications Planning & Activity
Communication Skills training - essential to help research projects reach the right stakeholders, at…
Effective & Entrepreneurial Communications Planning & Activity Training
Communication Skills training - essential to help research projects reach the right stakeholder…
University of Geneva present at the International Meeting on Marine Resources (IMMR2012)
University of Geneva recently gave an oral presentation at the International Meeting on Marine Resou…
University of Nice were invited to lecture for Symposium on Biotechnology and Biodiversity
University of Nice were recently invited to lecture at the Symposium on Biotechnology and Biodiv…
BAMMBO is a FP7 EU funded project which started in 2011.
It will provide innovative solutions to overcome existing bottle-necks associated with culturing marine organisms in order to sustainably produce high yields of value-added products for the pharmaceutical, cosmetic and industrial sectors. BAMMBO will screen and identify target marine organisms (e.g. bacteria, fungi, sponges, microalgae, macroalgae and yeasts) from diverse global locations for potential as sustainable producers of high–added value molecules (HVAB’s). Our project will apply analytical methods for the extraction, purification and enrichment of targeted bioactive compounds. A detailed life cycle analysis of the production pathways developed in the project will be undertaken to fully evaluate the sustainability of production of biologically active products from marine organisms.
BAMMBO will exploit knowledge and technologies developed during the project and effectively manage their transfer to relevant stakeholders in industry and the research community, as well as to policy-makers. Innovative technologies developed in the project will be demonstrated with the involvement of industry partners, and the results will be of interest not only to companies directly involved in the marine sector, but to other large scale industry players such as pharmaceutical companies with interest in added-value bioactive compounds.